Literature DB >> 10437989

New drugs on the horizon: matrix metalloproteinase inhibitors.

M L Rothenberg1, A R Nelson, K R Hande.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10437989     DOI： 10.1002/stem.170237

Source DB:  PubMed          Journal:  Stem Cells        ISSN： 1066-5099            Impact factor:   6.277


× No keyword cloud information.
  7 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.

Authors:  Jun Yong Choi; Rita Fuerst
Journal:  Methods Mol Biol       Date:  2017

Review 3.  MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.

Authors:  Yongqi Li; Weicheng Wang; Lei Li; Raouf A Khalil
Journal:  Life Sci       Date:  2020-04-10       Impact factor: 5.037

4.  Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.

Authors:  Aura D Urribarri; Patricia Munoz-Garrido; María J Perugorria; Oihane Erice; Maite Merino-Azpitarte; Ander Arbelaiz; Elisa Lozano; Elizabeth Hijona; Raúl Jiménez-Agüero; Maite G Fernandez-Barrena; Juan P Jimeno; Marco Marzioni; Jose J G Marin; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Jesús M Banales
Journal:  Gut       Date:  2014-01-16       Impact factor: 23.059

Review 5.  Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review).

Authors:  Marzena Wyganowska-Świątkowska; Mateusz Tarnowski; Daniel Murtagh; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2018-11-07       Impact factor: 4.101

Review 6.  Combined Radiochemotherapy: Metalloproteinases Revisited.

Authors:  Verena Waller; Martin Pruschy
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

7.  TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation.

Authors:  Everardus J van Zoelen; Isabel Duarte; José M Hendriks; Sebastian P van der Woning
Journal:  Stem Cell Res Ther       Date:  2016-08-26       Impact factor: 6.832
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.